Taysha Gene Therapies, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 06/05/2026 | Sep 2025Filed 04/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 06/05/2026 | Sep 2024Filed 04/11/2025 | Jun 2024Filed 12/08/2025 | Mar 2024Filed 15/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | $0 | $0 | $2 | $2.3 | $1.8 | $1.1 | $3.4 | |
| −$47 | −$42 | −$33 | −$27 | −$22 | −$26 | −$21 | −$24 | |
| −$0.13 | −$0.12 | −$0.09 | −$0.09 | −$0.08 | −$0.10 | −$0.09 | −$0.10 | |
| 369 | 367 | 353 | 298 | 269 | 268 | 233 | 231 |
Trend